Adding Vimpat to your current anti-seizure medication may provide better partial-onset seizure control. Vimpat has been proven to significantly reduce the number of partial-onset seizures. In clinical studies, more patients who added Vimpat reduced their partial-onset seizures by 50% or more versus those who added placebo. When Vimpat was used in combination with the most common epilepsy medicines, it was found to improve control of partial-onset seizures even in those who had tried multiple medications.
Look ahead to the possibility of a life with fewer seizures
When it comes to partial-onset seizure control, being just okay is not good enough. If your current level of seizure control isn’t where you want it to be, ask your neurologist if adding Vimpat is right for you.
Combining Vimpat with your current epilepsy treatment may:
- Provide additional partial-onset seizure control, even if you have tried or are currently taking multiple epilepsy medications
- Help difficult-to-treat patients reduce seizures when they have not gained seizure control from other medications
- Reduce partial-onset seizures by 50% or more
- Give you additional control without having to switch from your current epilepsy medication
In clinical trials, the most common side effects seen with Vimpat were dizziness, headache, nausea, and double vision. It is also important to note that antiepileptic drugs, including Vimpat, may cause suicidal thoughts or actions in a very small number of people, about 1 in 500. Call your healthcare provider right away if you have new or worsening symptoms of depression, any unusual changes in mood or behavior, or suicidal thoughts, behavior, or thoughts about self harm that you have never had before or may be worse than before. See additional important safety information below.
Vimpat® (lacosamide) is a prescription medicine that is used with other medicines to treat partial-onset seizures in people 17 years of age and older with epilepsy.
Important Safety Information
Vimpat may not be for everyone. Ask your healthcare provider if Vimpat is right for you.
Warnings and Precautions
Antiepileptic drugs, including Vimpat, may cause suicidal thoughts or actions in a very small number of people, about 1 in 500. Call your healthcare provider right away if you have new or worsening symptoms of depression, any unusual changes in mood or behavior, or suicidal thoughts, behavior, or thoughts about self harm that you have never had before or may be worse than before.
Do not stop taking VIMPAT without first talking to your healthcare provider. Stopping Vimpat suddenly can cause serious problems. Stopping seizure medicine suddenly in a patient who has epilepsy can cause seizures that will not stop.
Vimpat may also cause you to feel dizzy, have double vision, feel sleepy, or have problems with coordination and walking. You should not drive, operate machinery or do other dangerous activities until you know how Vimpat affects you.
Vimpat may cause you to have an irregular heartbeat or may cause you to feel faint. Call your healthcare provider if you have a fast, slow, or pounding heartbeat, shortness of breath, feel lightheaded, or if you fainted or feel like you are going to faint.
Vimpat is a federally controlled substance (C-V) because it can be abused or lead to drug dependence. Keep your Vimpat in a safe place to protect it from theft. Do not give it to anyone else, because it may harm them.
In rare cases, Vimpat may cause a serious allergic reaction that may affect your skin or other parts of your body such as your liver or blood cells. Call your healthcare provider right away if you have a skin rash or hives, fever or swollen glands that do not go away, shortness of breath, swelling of the legs, yellowing of the skin or whites of the eyes, or dark urine.
Before taking Vimpat, tell your healthcare provider if you have or have had depression, mood problems, or suicidal thoughts or behavior; have heart, kidney or liver problems; have abused prescription medicines, street drugs or alcohol in the past, are pregnant or plan to become pregnant.
Vimpat® oral solution contains aspartame, a source of phenylalanine.
Common Adverse Reactions
In clinical trials, the most common side effects seen with Vimpat were dizziness, headache, nausea, and double vision.
Talk to your healthcare provider about other possible side effects with VIMPAT. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
Please see additional patient information in the Patient Medication Guide. This information does not take the place of talking with your healthcare provider about your condition or your treatment.